Ophthalmic Business News

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Leanne Labriola, DO, MBA, president of InnSight Technology, discusses the OcuCheck biosensor, a tear film diagnostic device.

CHICAGO — In this video from Eyecelerator@AAO, SpyGlass Pharma CEO Patrick Mooney discusses the company’s drug delivery platform, which lowered IOP in patients with open-angle glaucoma or ocular hypertension.

CHICAGO — In this video from Eyecelerator@AAO, Visus Therapeutics CEO Ben Bergo discusses the company’s acquisition of ViewPoint’s patents and how this will help it further develop treatment options for presbyopia and cataracts.

CHICAGO — Avacincaptad pegol helped slow the rate of geographic atrophy growth compared with sham treatment, according to a study presented at Eyecelerator@AAO.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Shawn O’Neil of ViaLase discusses the company’s noninvasive OCT-driven femtosecond laser for glaucoma treatment.

CHICAGO — In this video from Eyecelerator@AAO, Opthea CEO Megan Baldwin, PhD, discusses updates for OPT-302, a therapy targeting a new mechanism of action for the treatment of wet age-related macular degeneration.

The FDA has approved Iheezo ophthalmic gel for ocular surface anesthesia, according to a joint press release from Harrow and Sintetica.

In this episode, I share my preview of the hot topics for the upcoming AAO 2022 annual meeting, including my thoughts on ocular gene therapy and new treatments in the works.

Dagny Zhu, MD, talks with Trina Spear and Heather Hasson, co-founders and co-CEOs of FIGS Scrubs, about they help female physicians feel confident and perform their best, their initiatives to celebrate healthcare workers and address gender disparities in the medical workforce and more.

Boy, what a long road TearLab has traveled. It seems like I’ve been talking to them and about them forever. Certainly since 2010.